.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Citi
Novartis
Fish and Richardson
Johnson and Johnson
Dow
Farmers Insurance
McKinsey
Fuji

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Other DrugPatentWatch Resources

Will an FDA rule for biosimilar names cost the health care system billions of dollars?

File this under 'unintended consequences.' A number of health care organizations are complaining that a final guideline the US Food and Drug Administration recently released for naming both biologic medicines and identical, but lower-cost biosimilar versions will cost the health care system billions of dollars in technology costs. How so? The guideline is designed to make…

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Related Resources

Back to DrugPatentWatch Resources

For more information try a trial or see the database preview and plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot